$FF

FutureFuel’s Q1 Income Hit By Winter Storm Production Pause

FutureFuel Corp. reported a wider Q1 loss of $20.6 million due to a 30-day production shutdown caused by severe winter weather, despite an 81.9% increase in revenue to $31.9 million, driven by strong growth in its chemicals segment. The company also saw a boost in biofuel sales following regulatory clarity, though biofuel production has paused again after a recent fire at its Batesville facility, which is currently being evaluated for repairs. FutureFuel is consolidating operations in Batesville after closing its Clayton, Missouri headquarters.

Original reporting
Arkansas Business · Arkansas Business Staff
Published May 12, 2026, 2:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 12, 2026, 2:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FutureFuel’s Q1 Income Hit By Winter Storm Production Pause — source image
Decision brief

The 30-second read

$FFBearishMed
01

Why it matters

Operational disruptions and recent fire have negatively impacted investor sentiment, overshadowing revenue growth. The company's consolidation efforts and regulatory clarity in biofuel markets present both risks and opportunities.

02

Market read

The news has moderate relevance for traders focusing on energy, manufacturing, and regional markets, with immediate implications for FF stock and related sectors.

03

What to watch

Potential for government or regulatory support to expedite repairs and mitigate losses, which could positively influence stock performance in the medium term.

Timing: Immediate, as the news is recent and impacts current operations.

Background

FutureFuel reported a Q1 loss of $20.6 million amid a 30-day production shutdown due to winter storms and a recent fire at its Batesville facility. Revenue increased by 81.9%, driven by growth in chemicals and biofuel segments.

Company-level read

Ticker impact

$FFBearishMedium confidence
Context

The news directly pertains to FutureFuel Corp. (FF), highlighting operational disruptions and financial performance.

Expected impact

Potential short-term decline of 5-10% due to operational setbacks and bearish sentiment.

Evidence & confidence

Operational disruptions and negative sentiment from recent events are likely to weigh on stock performance in the near term, though revenue growth indicates underlying business strength.

Market effects

Manufacturing and energy sectors may experience volatility due to operational disruptions at a key chemical and biofuel producer.

Potential regional impact in Arkansas and surrounding areas where operations are based.

Limited; primarily affects regional and sector-specific investors.

Counterpoint

Operational issues may be temporary; if the company demonstrates quick recovery and effective communication, the stock could rebound, offering a buying opportunity.

Key entities

  • FutureFuel Corp.

    A producer of chemicals and biofuels, operating primarily in Arkansas.

  • Batesville Facility

    The company's biofuel production site affected by fire and under evaluation for repairs.

Related articles

$FFMedAI 8/10

Biofuel Stock FutureFuel Corp. (NYSE: FF) Soars on Strong Second Quarter

FutureFuel Corp. (NYSE: FF) shares rose after it reported Q2 2026 results. The company said total revenue was $78.7 million, up 120.6% year over year, with GAAP net income of $11.4 million ($0.25 diluted) and adjusted EBITDA of $11.8 million. It also cited higher chemicals and biofuel revenue, improved production, and expects positive full-year 2026 adjusted EBITDA.

$FFMedAI 8/10

Why is FutureFuel stock surging today?

Investing.com reports FutureFuel Corp. shares rose 21.5% in pre-open trading after its Q2 2026 results. The company posted $78.7M revenue, up over 120% year over year, GAAP net income of $11.4M ($0.25/diluted share), and Adjusted EBITDA of $11.8M versus a $14.2M net loss in Q2 2025. Management cited stronger Chemicals demand and improved Biofuels regulation, reaffirming full-year 2026 guidance.

$FFMed

FutureFuel Corp. (FF): Results of Operations and Financial Condition

FutureFuel Corp. (FF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FUTUREFUEL ANNOUNCES SECOND QUARTER 2026 RESULTS BATESVILLE, Ark., August 10, 2026 – FutureFuel Corp . (NYSE: FF) (“FutureFuel” or the “Company”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarte

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.